Medical device and MedTech insights, news, tips and more

Neuronetics® and Success TMS Partner to Increase Patient Access to Leading Depression Treatment, NeuroStar® Advanced Therapy

October 28, 2019

Horizontal-Dr+Patient1_0

Neuronetics, Inc., a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced a partnership with Success TMS, a healthcare provider specializing in transcranial magnetic stimulation (TMS), a non-drug, non-invasive treatment for adult patients with Major Depressive Disorder (MDD). As part of a three-year agreement, Success TMS will offer Neuronetics’ NeuroStar Advanced Therapy system as its preferred TMS device at 21 locations across six states.

Horizontal-Dr+Patient1_0

Sparked by Founder Jonathan Michel’s personal journey losing his sister, Alex, to suicide after her five-year battle with the disease, the facility’s flagship location opened in 2018 in Lake Worth, FL to treat local residents. Michel and his leadership team have since pursued a far-reaching, rapidly-growing expansion strategy to provide compassionate care to depression sufferers. The practice has seen both organic and inorganic growth in the last year, with the aim of “ridding the world of depression” as per Alex’s last request.

Today, Success TMS is one of the leading TMS Therapy providers in the US, treating hundreds of patients each day and every day in Alex’s honor. Neuronetics is the global leader in TMS therapy for depression, and the uncompromised focus of both companies on maximizing patient outcomes led to this collaborative partnership. Success TMS has helped many patients with NeuroStar TMS, which uses magnetic pulses to stimulate areas of the brain that are underactive in depression.1,2

“The Success TMS team understands the hardship of depression firsthand. We’ve seen this disease in friends and loved ones and believe in the power of providing specialized care in order to maximize successful outcomes for patients,” said Randy Syrop, CEO and Co-Founder of Success TMS. “NeuroStar Advanced Therapy is the treatment that makes this possible. We know because we have seen it work, and we’re excited about this partnership because it means more sufferers will have access to this treatment, giving hope to those who need it most and offering true remission from this disease.”

Under the terms of the partnership, Success TMS will offer NeuroStar Advanced Therapy TMS systems at all its locations. This partnership is expected to allow for the treatment of thousands of patients across Success TMS’s clinic locations. Success TMS plans on continuing its aggressive growth by launching new clinics in both existing and new regions over the next 18 months, including four in South Florida by 2019 year end – MiamiCoral GablesKey Biscayne, and Boca Raton (successtms.com/locations).

“Success TMS is at the forefront of exceptional patient service, fueled by a very personal connection to depression,” said Chris Thatcher, President and CEO of Neuronetics, Inc. “We’re proud to expand our relationship with such a dedicated practice in a united fight against this disease that affects too many.”

See Full Press Release: Neuronetics® and Success TMS Partner to Increase Patient Access to Leading Depression Treatment, NeuroStar® Advanced Therapy


Written by: NeuroStart


Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.